Monday, April 21, 2025
Blogger Facebook Linkedin Pinterest Twitter Youtube

Tag: Phase IIa

PharmNovo

PharmNovo scores in neuropathic pain management 

HTP Desk - 0
Swedish pharmaceutical company PharmNovo has announced the positive final results from the Phase I trial of its neuropathic pain drug candidate, PN6047. This trial...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter Youtube
© 2024 All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!